Literature DB >> 9012478

Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: importance of 1q and 3p copy number changes in metastatic events.

J Gronwald1, S Störkel, H Holtgreve-Grez, P Hadaczek, C Brinkschmidt, A Jauch, J Lubinski, T Cremer.   

Abstract

Archival material from primary and metastatic renal clear cell carcinomas of 25 patients was studied by comparative genomic hybridization. Copy number changes of entire chromosomes or chromosomal subregions were detected in 22 primary and 21 metastatic tumors. Copy number changes affected the following chromosomes in at least 20% of the 25 primary tumors (minimal common region given in parentheses): gains were noted for chromosomes 1 (1q21-->q23), 5 (5q31-->q34), 7 (7p), 8 (8q), 16 (16p), 17 (17q12-->qter), 19, and 22 (22q12-->qter); losses were revealed for chromosomes 3 (3p21-->pter), 8 (8p23-->pter), 14(14q21-->qter), and Y. The same chromosomal regions that were involved in primary renal clear cell carcinomas were also found in the respective metastatic tumors but with strikingly different frequencies for a few regions. Metastatic tumors showed a significantly higher frequency of complete or partial gains of the long arm of chromosome 1, in particular at 1q21-->q23 than primary tumors (16 cases versus 6 cases; P < 0.005). These data suggest a correlation of metastatic events in renal clear cell carcinomas with an increase in the copy number of genes located at 1q, in particular at 1q21-->q23. In contrast, the entire or partial loss of the short arm of chromosome 3 was significantly less frequent in metastatic tumors (8 cases versus 15 cases; P < 0.025). The validity of 1q and 3p copy number changes detected by comparative genomic hybridization was confirmed by interphase cytogenetics with region-specific yeast artificial chromosomes to paraffin-embedded tumor tissue sections.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9012478

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  24 in total

Review 1.  DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies.

Authors:  S Knuutila; A M Björkqvist; K Autio; M Tarkkanen; M Wolf; O Monni; J Szymanska; M L Larramendy; J Tapper; H Pere; W El-Rifai; S Hemmer; V M Wasenius; V Vidgren; Y Zhu
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

Review 2.  Chromosome 1q21 amplification and oncogenes in hepatocellular carcinoma.

Authors:  Leilei Chen; Tim Hon Man Chan; Xin-yuan Guan
Journal:  Acta Pharmacol Sin       Date:  2010-08-02       Impact factor: 6.150

3.  Evaluation of the clonal relationship between primary and metastatic renal cell carcinoma by comparative genomic hybridization.

Authors:  H Bissig; J Richter; R Desper; V Meier; P Schraml; A A Schäffer; G Sauter; M J Mihatsch; H Moch
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

4.  Clear cell renal cell carcinoma: a comparative study of histological and chromosomal characteristics between primary tumors and their corresponding metastases.

Authors:  Julien Dagher; Solène-Florence Kammerer-Jacquet; Frédéric Dugay; Marion Beaumont; Alexandra Lespagnol; Laurence Cornevin; Grégory Verhoest; Karim Bensalah; Nathalie Rioux-Leclercq; Marc-Antoine Belaud-Rotureau
Journal:  Virchows Arch       Date:  2017-05-10       Impact factor: 4.064

5.  DNA copy number changes in development and progression in leiomyosarcomas of soft tissues.

Authors:  W El-Rifai; M Sarlomo-Rikala; S Knuutila; M Miettinen
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

Review 6.  Chromosomal aberrations related to metastasis of human solid tumors.

Authors:  Lun-Xiu Qin
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

7.  Integrative genome comparison of primary and metastatic melanomas.

Authors:  Omar Kabbarah; Cristina Nogueira; Bin Feng; Rosalynn M Nazarian; Marcus Bosenberg; Min Wu; Kenneth L Scott; Lawrence N Kwong; Yonghong Xiao; Carlos Cordon-Cardo; Scott R Granter; Sridhar Ramaswamy; Todd Golub; Lyn M Duncan; Stephan N Wagner; Cameron Brennan; Lynda Chin
Journal:  PLoS One       Date:  2010-05-24       Impact factor: 3.240

8.  High fidelity of driver chromosomal alterations among primary and metastatic renal cell carcinomas: implications for tumor clonal evolution and treatment.

Authors:  Eril J Kouba; John N Eble; Novae Simper; David J Grignon; Mingsheng Wang; Shaobo Zhang; Lisha Wang; Guido Martignoni; Sean R Williamson; Matteo Brunelli; Claudio Luchini; Anna Calió; Liang Cheng
Journal:  Mod Pathol       Date:  2016-07-29       Impact factor: 7.842

9.  Relevance of nuclear and cytoplasmic von hippel lindau protein expression for renal carcinoma progression.

Authors:  Peter Schraml; Alexander Hergovich; Florian Hatz; Mahul B Amin; So D Lim; Wilhelm Krek; Michael J Mihatsch; Holger Moch; Alexander Hergovitz
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

10.  Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney.

Authors:  Rameen Beroukhim; Jean-Philippe Brunet; Arianna Di Napoli; Kirsten D Mertz; Apryle Seeley; Maira M Pires; David Linhart; Robert A Worrell; Holger Moch; Mark A Rubin; William R Sellers; Matthew Meyerson; W Marston Linehan; William G Kaelin; Sabina Signoretti
Journal:  Cancer Res       Date:  2009-06-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.